Virtual group program using continuous glucose monitors, education, and peer support for uncontrolled type 2 diabetes
The COMPASS Program: Continuous Monitoring, Peer And Structured Support for Management of Uncontrolled Type 2 Diabetes - A Prospective Single-Arm Study
This program will try using continuous glucose monitors together with virtual group education and peer support to help adults with type 2 diabetes and A1c over 8% lower their blood sugars and feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Whole Endo Industry-sponsored |
| Locations | 1 site (Asheville, North Carolina) |
| Trial ID | NCT07054125 on ClinicalTrials.gov |
What this trial studies
This observational program enrolls adults with poorly controlled type 2 diabetes (A1c > 8%) who have a smartphone to connect with a continuous glucose monitor (CGM). Participants join virtual group visits where clinicians and peers discuss how to use and interpret CGM data, plus nutrition, physical activity, stress reduction, and habit-starting techniques. The intervention combines device-based glucose feedback, diabetes education, lifestyle counseling, and peer support rather than changes to medication mandated by the protocol. The study is run by Whole Endo with collaboration from DexCom and collects outcomes on glucose measures and quality of life over the intervention period.
Who should consider this trial
Good fit: Adults aged 18 or older with type 2 diabetes and A1c above 8% who have a smartphone and are willing to use a CGM and attend virtual group visits are ideal candidates.
Not a fit: People with type 1 diabetes, those who are pregnant, on active cancer treatment or high-dose steroids, on dialysis for end-stage renal disease, or with dementia/major cognitive impairment (or without a smartphone/unwilling to use a CGM) are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, the program could help people lower average glucose and A1c and improve day-to-day diabetes self-management and quality of life.
How similar studies have performed: Prior studies have shown CGM use and structured education can improve glycemic control in type 2 diabetes, though combining virtual group visits with peer support is less extensively studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older * Diagnosed with type 2 diabetes mellitus Hemoglobin A1c \>8% Must have smartphone to connect with continuous glucose monitor Exclusion Criteria: * Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis
Where this trial is running
Asheville, North Carolina
- Whole Endo — Asheville, North Carolina, United States (Recruiting)
Study contacts
- Study coordinator: Rashim Gupta, MD
- Email: rashim.gupta@wholeendo.com
- Phone: 980-349-6036
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.